Stockscreener 앱 받기
1.07
0.94%
0.01
Connect Biopharma Holdings Ltd Adr 주식(CNTB)의 최신 뉴스
Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewswire Inc.
Connect Biopharma begins Phase 2 asthma study - Investing.com
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com
FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com
Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com
Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India
Connect Biopharma faces Nasdaq delisting over share price - Investing.com
Connect Biopharma stock hits 52-week low at $0.76 - Investing.com
Connect Biopharma stock hits 52-week low at $0.91 amid market challenges - Investing.com India
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
Top 3 Aerospace and Defense Stocks Flying Under the Radar - The Globe and Mail
CPIX Stock Quote Price and Forecast - CNN
Stocks Set to Open Lower as Investors Await Fed Meeting, Banking Sector Remains in Focus - Barchart.com
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - USC-China Institute
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
Connect Biopharma Holdings Limited: Shareholders Board Members Managers and Company Profile | US2075231017 - Marketscreener.com
Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat
0.99%
0.39%
자본화:
|
볼륨(24시간):